HRSA Debates Adding Rare MLD to Newborn Disease Screening Panel
Published Date: 8/14/2025
Notice
Summary
HRSA is thinking about adding Metachromatic Leukodystrophy (MLD), a serious condition, to the list of diseases newborns get screened for. This means babies could be tested early without families paying extra, helping catch MLD sooner and possibly save lives. HRSA wants your thoughts before making a final call, so speak up soon!
Analyzed Economic Effects
3 provisions identified: 2 benefits, 0 costs, 1 mixed.
If Added, Screening Covered Without Cost-Sharing
If HRSA adds Metachromatic Leukodystrophy (MLD) to the Recommended Uniform Screening Panel (RUSP), newborn screening for MLD that is included in HRSA-supported comprehensive guidelines must be covered by non-grandfathered health plans without cost-sharing (no co-payment or co-insurance).
Supports Early Newborn Screening for MLD
HRSA is considering recommending MLD be added to the RUSP to support screening during the newborn period and is specifically asking for evidence about the potential benefit of early screening and the availability of effective treatments for MLD.
State Screening Capacity Will Be Considered
HRSA will consider the ability of state newborn screening programs to screen for MLD when deciding whether to recommend adding MLD to the RUSP, so state program capacity is part of the decision process.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11828 — Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Delta States Rural Development Network Grant Program, OMB No. 0915-0386-Revision
HRSA is updating how it collects info from groups getting grants to fight heart disease, diabetes, stroke, and obesity in rural Delta communities. They want your thoughts by July 13, 2026, before finalizing these changes. This helps make sure the program stays effective, easy to track, and ready to grow without extra costs.
2026-10850 — Notice of Supplemental Funding for the Black Lung Data and Resource Center
The Health Resources and Services Administration is giving an extra $50,000 to the University of Illinois, Chicago to help the Black Lung Data and Resource Center improve how they collect and analyze patient data. This funding runs from July 1, 2026, to June 30, 2027, and will boost clinic operations and services for people affected by black lung disease. It’s a one-time award to make sure clinics get better support and care.
2026-10469 — Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Health Professions Student Loan Program, Loans for Disadvantaged Students Program, Primary Care Loan Program, and Nursing Student Loan Program Administrative Requirements, OMB No. 0906-0088-Extension
HRSA is asking for public feedback on extending the paperwork rules for four student loan programs that help future health professionals, especially those from disadvantaged backgrounds. If you’re involved with these loans, your input matters before July 27, 2026. No big changes or costs are planned—just keeping things running smoothly for students and schools.
2026-10278 — National Vaccine Injury Compensation Program: Revised Amount of the Average Cost of a Health Insurance Policy
The National Vaccine Injury Compensation Program just updated the average monthly cost of a health insurance policy to $742.53. This change affects anyone involved in vaccine injury claims and helps keep compensation fair and up-to-date. The new amount took effect as soon as it was sent to the Court in 2026, reflecting a 5% increase from last year.
2026-10077 — Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: National Health Service Corps Scholar/Students to Service Travel Worksheet, OMB No. 0906-0087-Revision
The National Health Service Corps is updating its Travel Worksheet used by scholarship and loan repayment participants to request travel and relocation funds for approved health sites. This change aims to make the process smoother and more accurate. If you’re part of these programs, you can comment on the update until July 20, 2026, with no new costs expected.
2026-10081 — Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Standardized Work Plan Form for Use With Applications to the Bureau of Health Workforce Research and Training Grants and Cooperative Agreements, OMB No. 0906-0049-Revision
HRSA is updating the Standardized Work Plan form used by people applying for health workforce research and training grants. This change helps everyone clearly show their project goals and track progress better. If you’re applying for or managing these grants, you can comment on the update by June 22, 2026—no extra costs involved, just smoother paperwork!
Previous / Next Documents
Previous: 2025-15431 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings this fall to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide which science projects get funding. If you’re a researcher waiting on grant news, these dates in September and October 2025 are key moments for your proposals.
Next: 2025-15433 — Notice With Request for Comment: Consideration of Adding Duchenne Muscular Dystrophy to the Recommended Uniform Screening Panel
HRSA is thinking about adding Duchenne Muscular Dystrophy (DMD) to the list of diseases newborns get screened for right after birth. This change would help babies with DMD get diagnosed early, and health plans would cover the screening without extra costs. HRSA wants your thoughts on how useful early screening is, if states can do it, and if good treatments are ready.